Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Mederos

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Revue Medicale Suisse|May 17, 2018
[High grade serous ovarian cancer 2018 : advances and controversies]Nuria Mederos, Anita Wolfer, Patrice Mathevet, et al.
Revue Medicale Suisse|May 17, 2023
[Salivary gland cancer: new therapeutic approaches]Ruth Gabriela Herrera Gomez, Nuria Mederos, Petr Szturz, et al.
Cancer Journal (Sudbury, Mass.)|January 26, 2011
Predicting response to chemotherapy with early-stage lung cancerRafael Rosell, Miquel Taron, Bartomeu Massuti, et al.
Revue Medicale Suisse|May 18, 2026
[Stereotactic radiotherapy of inoperable localized lung cancers]Nicolas Danthez, Nicolas Coquoz, Alban Lovis, et al.
Revue Medicale Suisse|May 18, 2022
[Targeted therapies and non-small cell carcinomas : novelties]Roberta Stauber, Louis Gro S, Tu Nguyen-Ngoc, et al.
Revue Medicale Suisse|May 16, 2019
[The new management options for lung cancer in the immunotherapy era]Heyfa Meganem, Roxana-Maria Socianu, Hasna Bouchaab, et al.
Revue Medicale Suisse|May 29, 2020
[Small-cell lung cancer: management and novelties]Karim Abdelhamid, Artemisia Kakourou, Nils Degrauwe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 21, 2020
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related CholangiohepatitisLaura Moi, Hasna Bouchaab, Nuria Mederos, et al.
Revue Medicale Suisse|May 18, 2022
[Management of brain metastases in 2022]Luis Schiappacasse, Rémy Kinj, Rita De Micheli, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Revue Medicale Suisse|May 17, 2018
[High grade serous ovarian cancer 2018 : advances and controversies]Nuria Mederos, Anita Wolfer, Patrice Mathevet, et al.
Revue Medicale Suisse|May 17, 2023
[Salivary gland cancer: new therapeutic approaches]Ruth Gabriela Herrera Gomez, Nuria Mederos, Petr Szturz, et al.
Cancer Journal (Sudbury, Mass.)|January 26, 2011
Predicting response to chemotherapy with early-stage lung cancerRafael Rosell, Miquel Taron, Bartomeu Massuti, et al.
Revue Medicale Suisse|May 18, 2026
[Stereotactic radiotherapy of inoperable localized lung cancers]Nicolas Danthez, Nicolas Coquoz, Alban Lovis, et al.
Revue Medicale Suisse|May 18, 2022
[Targeted therapies and non-small cell carcinomas : novelties]Roberta Stauber, Louis Gro S, Tu Nguyen-Ngoc, et al.
Revue Medicale Suisse|May 16, 2019
[The new management options for lung cancer in the immunotherapy era]Heyfa Meganem, Roxana-Maria Socianu, Hasna Bouchaab, et al.
Revue Medicale Suisse|May 29, 2020
[Small-cell lung cancer: management and novelties]Karim Abdelhamid, Artemisia Kakourou, Nils Degrauwe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 21, 2020
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related CholangiohepatitisLaura Moi, Hasna Bouchaab, Nuria Mederos, et al.
Revue Medicale Suisse|May 18, 2022
[Management of brain metastases in 2022]Luis Schiappacasse, Rémy Kinj, Rita De Micheli, et al.
Pageof 3